Catalyst Wire Dossier Catalyst Wire Dossier

0.25% bupivacaine

bupivacaine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.25% bupivacaine, covering 2020-03-20 to 2020-03-20. Get the full timeline:

Most recent: Clinical Trial Update: 0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka [Phase 3]

See pricing